Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Seabelife Receives Close to €1.4m Deep Tech Financing from Bpifrance
SeaBeLife, a biotech company developing drug candidates intended to block cell necrosis, today announces that […]
Zeta Surgical Raises $5.2M in Seed Financing to Enhance Surgical Navigation with Robotics and Mixed Reality
Zeta Surgical, a surgical robotics and mixed reality company, announced today the close of a $5.2M financing […]
Fluent BioSciences Awarded $1.7 Million SBIR Grant to Commercialize PIPseq™, a Breakthrough Platform Technology Enabling Scalable, Sensitive Single-cell Analysis in Any Laboratory
Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every […]
Scenic Biotech Announces $31 Million Financing to Progress Pipeline of Genetic Modifiers in Cancer and Rare Diseases
Scenic Biotech BV (“Scenic”), a pioneer in the discovery of genetic modifiers to enable the […]
Exosome-based Company Raised 5 M€ for the Development of Its New Biomedicine and Vaccines
Ciloa, a pioneer company expert in the in vivo customization of exosomes, announced today that […]
Flow Eighteen38 Receives €5 Million EUR (c.$5.58 Million USD) to Expand Production and Biophysical Capabilities
Flow Eighteen38, a protein sciences division created to facilitate and accelerate antibody characterization and protein […]
Maverick Medical AI Closes a $5M Seed Investment Round for Accelerating Development of its mCoder™ Artificial Intelligence Platform for Additional Clinical Domains
Maverick Medical AI (“Maverick”, the “Company”) has announced that it has closed a $5 million seed investment from […]
European Investment Bank to Provide a €7.5 Million Loan to Support Further Research and Development of Diadem's AlzoSure® Predict Blood Test for Alzheimer's Disease
The European Investment Bank (EIB) has awarded a €7.5 million loan to Diadem Srl, a […]
InxMed Raised $50 million in Series B Financing to Advance Innovative Therapies to Drug-resistance Cancers
InxMed Co., Ltd, a clinical-stage biotechnology company dedicated to developing innovative therapies targeting stroma microenvironment and drug […]
Lynx Introduces Modern FinTech to Healthcare—Launches with $17.5M in Funding
Lynx, the leading API-connected healthcare payments, banking, and e-commerce platform, announced today that it has emerged […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more